A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2001
12/26/2001	CN1328466A Use of antifungal agents for treating scleroses
12/26/2001	CN1328454A Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
12/26/2001	CN1327841A Medicine for treating rheumatoid arthritis
12/26/2001	CN1327799A Mixture of white pepper and borneol and its application
12/26/2001	CN1327796A Medicine for treating cervical vertebra disease by injection method
12/26/2001	CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/26/2001	CN1076618C Liquid medicine for treating wound and pain and preparing process thereof
12/26/2001	CN1076617C Medicine specially for treating caput femoris necrosis, and method for preparing same
12/26/2001	CN1076615C Chinese medicine powder for setting bone
12/26/2001	CN1076614C Exterior-applied powder medicine for treating lumbar intervertebral disk protrusion and preparing process
12/26/2001	CN1076604C Slow releasing agent of tuduvanine and its preparing method
12/25/2001	US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics
12/25/2001	US6333325 Method of treating cytokine mediated diseases or conditions
12/25/2001	US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases
12/25/2001	CA2094027C Osteogenic peptides
12/20/2001	WO2001096565A2 Binding agents: chimeric ligand/receptor proteins
12/20/2001	WO2001096547A2 Human kinases
12/20/2001	WO2001096546A2 Protein phosphatases
12/20/2001	WO2001096397A2 Cd154 variants and uses thereof
12/20/2001	WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
12/20/2001	WO2001096336A2 6,5-fused bicyclic heterocycles
12/20/2001	WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists
12/20/2001	WO2001096331A1 Lactam inhibitors of factor xa and method
12/20/2001	WO2001096330A2 Thrombin receptor antagonists
12/20/2001	WO2001096323A1 Serine protease inhibitors
12/20/2001	WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
12/20/2001	WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/20/2001	WO2001096305A1 Serine protease inhibitors
12/20/2001	WO2001096300A1 Growth hormone secretagogues
12/20/2001	WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	WO2001096296A1 Serine protease inhibitors
12/20/2001	WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments
12/20/2001	WO2001096285A1 Beta-amino acid nitrile derivatives
12/20/2001	WO2001095929A2 Interferon for treatment of multiple sclerosis
12/20/2001	WO2001095911A1 Protease inhibitors
12/20/2001	WO2001088108A8 Neuronal serine-threonine protein kinase
12/20/2001	WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors
12/20/2001	WO2001053531A3 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells
12/20/2001	WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
12/20/2001	WO2001031016A3 Processed human chemokines phc-1 and phc-2
12/20/2001	WO2001013949A3 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases
12/20/2001	US20010053853 Alkanoic acid derivative; integrin receptor antagonist
12/20/2001	US20010053777 Synergistic mixture containing alpha 2-antagonist agent and neuropsychic drug
12/20/2001	US20010053774 Non-steroidal ligands for the estrogen receptor
12/20/2001	US20010053763 Method and composition for modulating an immune response
12/20/2001	US20010053388 Containing a bisphosphonate acid or its pharmaceutically acceptable salt dissolved in an aqueous solution, and a polymeric gel forming agent capable of inhibiting diffusion of the active ingredient with human tissue.
12/20/2001	US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001	US20010053351 Inhibition of GSK-3 beta
12/20/2001	DE10028402A1 New pyridinylamino-alkanoyl-glycyl-beta-alanine derivatives, are integrin inhibitors useful for treating, e.g. thrombosis, cardiac infarction, coronary heart disease, inflammation, tumors, osteoporosis or restenosis
12/20/2001	DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase
12/20/2001	CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments
12/20/2001	CA2413077A1 Interferon for treatment of multiple sclerosis
12/20/2001	CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	CA2412632A1 Hmg-coa reductase inhibitors and method
12/20/2001	CA2412462A1 6,5-fused bicyclic heterocycles
12/20/2001	CA2412353A1 Protease inhibitors
12/20/2001	CA2412216A1 Lactam inhibitors of factor xa and method
12/20/2001	CA2411805A1 Serine protease inhibitors
12/20/2001	CA2411798A1 Serine protease inhibitors
12/20/2001	CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2409315A1 Protein phosphatases
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163274A1 Process for cross-linking hyaluronic acid to polymers
12/19/2001	EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163237A1 Amide derivatives
12/19/2001	EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001	EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001	EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP1163212A1 Amide derivatives
12/19/2001	EP1163204A1 Lipoxin compounds and their use
12/19/2001	EP1162997A2 Staphylococcus antigen and vaccine
12/19/2001	EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
12/19/2001	EP1162937A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration
12/19/2001	EP0906092B1 Pharmaceutical compositions based on diclofenac
12/19/2001	EP0828742B1 Diazepino-indoles as phosphodiesterase iv inhibitors
12/19/2001	EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
12/19/2001	EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
12/19/2001	CN1327443A Substituted anilides
12/19/2001	CN1327382A Improved formulation for topical non-invasive application in vivo
12/19/2001	CN1326773A Medicine for curing hyperosteogeny
12/19/2001	CN1326757A Medicinal composition for curing protrusion of lumber intervertebral disc
12/18/2001	US6331642 Vitamin D3 analogs
12/18/2001	US6331640 Diaminopropionic acid derivatives
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331612 Bone morphogenic protein-16 (BMP-16) compositions
12/18/2001	US6331562 Compounds and methods for modulation of estrogen receptors
12/18/2001	US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331542 Protease inhibitors

1 ... 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 ... 820